CARL
Carlsmed, Inc.
18.60
+3.89 (+26.44%)
52w low 8.50
17.23 high
100.0% of range
Financial Analysis
| (USD) | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|
| Cash & Equivalents | 7.22M | 40.12M | 85.79M | |
| Receivables | 3.17M | 6.77M | 11.36M | |
| Inventory | 575.00K | 995.00K | 1.84M | |
| Current Assets | 11.77M | 49.35M | 126.67M | |
| Net PP&E | 2.24M | 1.90M | 3.31M | |
| Total Assets | 14.02M | 51.82M | 130.12M | |
| Current Liabilities | 7.44M | 8.82M | 14.28M | |
| Total Debt | 11.39M | 17.18M | 17.41M | |
| Total Liabilities | 60.15M | 122.45M | 31.25M | |
| Retained Earnings | -46.91M | -71.17M | -100.81M | |
| Shareholders Equity | -46.13M | -70.63M | 98.87M | |
| Working Capital | 4.33M | 40.53M | 112.39M | |
| Shares Outstanding | 26.52M | 26.52M | 26.66M |
Revenue CAGR
+91.5%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+85.9%